| Literature DB >> 28082418 |
Chin-Yu Lin1,2,3, Yenn-Jiang Lin1,2, Cheng-Hung Li1,2,4, Fa-Po Chung1,2, Men-Tzung Lo5, Chen Lin5, Hsiang-Chih Chang5, Shih-Lin Chang1,2, Li-Wei Lo1,2, Yu-Feng Hu1,2, Yao-Ting Chang1,2, Chung-Hsing Lin1,2, Yun-Yu Chen1,6, Rohit Walia2, Abigail Louise D Te2, Shinya Yamada2, Tsu-Juey Wu4, Shih-Ann Chen1,2.
Abstract
Aims: Whether the distribution of scar in arrhythmogenic right ventricular cardiomyopathy (ARVC) plays a role in predicting different types of ventricular arrhythmias is unknown. This study aimed to investigate the prognostic value of scar distribution in patients with ARVC. Methods and results: We studied 80 consecutive ARVC patients (46 men, mean age 47 ± 15 years) who underwent an electrophysiological study with ablation. Thirty-four patients receive both endocardial and epicardial mapping. Abnormal endocardial substrates and epicardial substrates were characterized. Three groups were defined according to the epicardial and endocardial scar gradient (<10%: transmural, 10-20%: intermediate, >20%: horizontal, as groups 1, 2, and 3, respectively). Sinus rhythm electrograms underwent a Hilbert-Huang spectral analysis and were displayed as 3D Simultaneous Amplitude Frequency Electrogram Transformation (SAFE-T) maps, which represented the arrhythmogenic potentials. The baseline characteristics were similar between the three groups. Group 3 patients had a higher incidence of fatal ventricular arrhythmias requiring defibrillation and cardiac arrest during the initial presentation despite having fewer premature ventricular complexes. A larger area of arrhythmogenic potentials in the epicardium was observed in patients with horizontal scar. The epicardial-endocardial scar gradient was independently associated with the occurrence of fatal ventricular arrhythmias after a multivariate adjustment. The total, ventricular tachycardia, and VF recurrent rates were higher in Group 3 during 38 ± 21 months of follow-up.Entities:
Mesh:
Year: 2018 PMID: 28082418 DOI: 10.1093/europace/euw393
Source DB: PubMed Journal: Europace ISSN: 1099-5129 Impact factor: 5.214